Cytomegalovirus viremia, pneumonitis, and tocilizumab therapy

Emerg Infect Dis. 2011 Apr;17(4):754-6. doi: 10.3201/eid1706.101057.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Cytomegalovirus / physiology*
  • Cytomegalovirus Infections* / complications
  • Cytomegalovirus Infections* / drug therapy
  • Cytomegalovirus Infections* / virology
  • Ganciclovir / therapeutic use
  • Humans
  • Male
  • Pneumonia* / complications
  • Pneumonia* / drug therapy
  • Treatment Outcome
  • Viremia* / drug therapy
  • Viremia* / virology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • tocilizumab
  • Ganciclovir